» Articles » PMID: 38362014

Presence and Onset of Chronic Kidney Disease As a Factor Involved in the Poor Prognosis of Patients with Essential Thrombocythemia

Overview
Journal Adv Hematol
Publisher Wiley
Specialty Hematology
Date 2024 Feb 16
PMID 38362014
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic kidney disease (CKD) is an important risk factor for cardiovascular disease, thrombosis, and all-cause death. However, few studies have examined the association between CKD and the prognosis of patients with essential thrombocythemia (ET). We collected ET patients who met the WHO classification 2017 and performed a retrospective clinical study to clarify the association between the presence and onset of CKD and prognosis. Of 73 patients who met the diagnostic criteria, 21 (28.8%) had CKD at the time of ET diagnosis. The age of patients with CKD was significantly higher, and a high proportion of these patients had the V617F gene mutation. The presence of CKD was a risk factor for the prognosis (hazard ratio (HR): 3.750, 95% confidence interval (CI): 1.196-11.760, =0.023), and the survival curve was significantly poorer. Furthermore, we analyzed patients without CKD at the time of ET diagnosis using the onset of CKD as a time-dependent variable and identified the onset of CKD as a risk factor for the prognosis (HR: 9.155, 95% CI: 1.542-54.370, =0.005). In patients with renal hypofunction at the time of ET diagnosis or those with a reduction in the kidney function during follow-up, strict renal function monitoring at regular intervals is necessary.

References
1.
Tefferi A, Guglielmelli P, Larson D, Finke C, Wassie E, Pieri L . Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis. Blood. 2014; 124(16):2507-13. PMC: 4199952. DOI: 10.1182/blood-2014-05-579136. View

2.
James C, Ugo V, Le Couedic J, Staerk J, Delhommeau F, Lacout C . A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature. 2005; 434(7037):1144-8. DOI: 10.1038/nature03546. View

3.
Hallan S, Coresh J, Astor B, Asberg A, Powe N, Romundstad S . International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol. 2006; 17(8):2275-84. DOI: 10.1681/ASN.2005121273. View

4.
Folsom A, Lutsey P, Astor B, Wattanakit K, Heckbert S, Cushman M . Chronic kidney disease and venous thromboembolism: a prospective study. Nephrol Dial Transplant. 2010; 25(10):3296-301. PMC: 2948836. DOI: 10.1093/ndt/gfq179. View

5.
Hashimoto Y, Ito T, Gotoh A, Nakamae M, Kimura F, Koike M . Clinical characteristics, prognostic factors, and outcomes of patients with essential thrombocythemia in Japan: the JSH-MPN-R18 study. Int J Hematol. 2021; 115(2):208-221. DOI: 10.1007/s12185-021-03253-0. View